BiologicsCreate better biologic treatments and speed your path to market with our range of advanced technologies and services. Learn More Catalent Partnering with Multiple Customers on COVID-Related Vaccines and TherapiesIncluding Johnson & Johnson, AstraZeneca, Moderna and Humanigen Learn More Catalent Completes Acquisition of Manufacturing Facility from Bone TherapeuticsExpanding its industry-leading cell therapy capabilities and advanced clinical and commercial supply in Belgium Learn More Developing Biologic Drugs is Science.Accelerating Advanced Treatments & Vaccines is Art. Learn More BiologicsCreate better biologic treatments and speed your path to market with our range of advanced technologies and services. Learn More Catalent Partnering with Multiple Customers on COVID-Related Vaccines and TherapiesIncluding Johnson & Johnson, AstraZeneca, Moderna and Humanigen Learn More Catalent Completes Acquisition of Manufacturing Facility from Bone TherapeuticsExpanding its industry-leading cell therapy capabilities and advanced clinical and commercial supply in Belgium Learn More Developing Biologic Drugs is Science.Accelerating Advanced Treatments & Vaccines is Art. Learn More How can we work together BiologicsDevelopment Gene Therapy Cell Therapy Technologies Latest News Catalent Completes Acquisition of Cell Therapy Manufacturing Facility from Bone Therapeutics CATALENT RESPONDS TO THE GLOBAL COVID-19 OUTBREAK We are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, partners, customers, and their patients. LEARN MORE Cell Therapy With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, Catalent is your full-service partner for CAR-T immunotherapies and beyond. Gene Therapy Our Gene Therapy team combines leading expertise in viral vector technology and scale-up with state-of-the-art CGMP facilities, including our FDA approved commercial facility. STRATEGIES TO ACHIEVE SUCCESSFUL COMMERCIAL APPROVAL & LAUNCH Experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the successful launch and approval of a biologic. Biologics Network Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world. SEE ALL LOCATIONS Join Our Team Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team. NEWS Catalent Appoints Dr. Behzad Mahdavi as Vice President of Open Innovation, Biologics, Cell and Gene Therapy Catalent Completes Acquisition of Cell Therapy Manufacturing Facility from Bone Therapeutics Taysha Gene Therapies Bolsters Manufacturing Capacity Through Partnership with Catalent Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn® VIEW ALL NEWS EVENTS Women in Biopharma: Celebrating the Top 20 Leaders in Biopharma R&D Webinar: Exploring New & Improved Analytical Methods for Traditional & Unique Modalities JPMorgan Week 2021 Virtual Series Gene Therapy for Rare Disorders VIEW ALL EVENTS EXPERT CONTENT Advances in Analytical Technology for Biopharmaceuticals Prefilled Syringes & Parental Manufacturing Accelerating Method Transfer: Effective Automation Of Biological Assays VIEW ALL ARTICLES
